Kuros Biosciences AG (KURN) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.53x

Kuros Biosciences AG (KURN) has a Cash Flow Reinvestment Rate of 0.53x as of December 2025, reinvesting CHF1.03 Million (capex CHF1.03 Million ) from operating cash flow of CHF1.94 Million. Explore Kuros Biosciences AG capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.53x

(Capex + Investments) / Operating CF

Total Reinvested

CHF1.03 Million

Capex + Investments

Operating Cash Flow

CHF1.94 Million

CHF

Capital Expenditures

CHF1.03 Million

CHF

Kuros Biosciences AG Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for Kuros Biosciences AG across 1 annual periods. Also explore KURN current and non-current assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Kuros Biosciences AG (2024–2024)

Year-by-year capital reinvestment analysis for Kuros Biosciences AG. For live market cap and broader valuation context, see Kuros Biosciences AG (KURN) market capitalisation.

Year	Reinvestment Rate	Total Reinvested (CHF)	Operating CF	Capex	YoY Change
2024	0.71x	CHF2.22 Million	CHF3.14 Million	CHF1.11 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow